Navigation Links
Bacchus Vascular Names Scott Cramer as President and CEO
Date:10/16/2007

Experienced Sales Executive to Lead Growing Medical Device Firm

SANTA CLARA, Calif., Oct. 16 /PRNewswire/ -- Bacchus Vascular Inc., a leading provider of innovative medical devices used by interventional radiologists and vascular surgeons for the minimally invasive treatment of deep vein thrombosis (DVT) and other peripheral vascular disease, announced today that it has named Scott Cramer to the position of President and Chief Executive Officer.

Mr. Cramer joined Bacchus Vascular earlier this year as Senior Vice President of Sales. Previously he served as Senior Vice President of U.S. Sales and Account Services for VNUS Medical Technologies (Nasdaq: VNUS) from 2000 until April, 2007. Prior to that, Mr. Cramer held senior management positions with EndoSonics Corporation and Cardiometrics, Inc., as well as management positions with Baxter Healthcare Corporation's cardiovascular division. Mr. Cramer holds a B.S. degree in Finance from the Philadelphia University.

"Scott Cramer has a broad background in the vascular disease and interventional field, a strong track record of introducing innovative medical technologies, and proven success developing new markets," said Elizabeth H. (Bess) Weatherman, Managing Director, Healthcare - Medical Devices for Warburg Pincus LLC, and a Director of Bacchus Vascular.

"Scott brings a wealth of experience to Bacchus Vascular, and we look forward to his leadership in the next phase of the Company's growth," added Thomas Fogarty, MD, Chairman of the Board of Bacchus Vascular.

The Company's previous President and CEO, R. Scott Rader, is relocating to the east coast to fulfill family obligations and pursue other business opportunities. He will remain on the Board of Directors of Bacchus Vascular.

"Scott Rader successfully led Bacchus Vascular through three years of product development, market introduction and clinical success with the Trellis device. We are grateful for his skilled leadership during this stage of the Company's development and are pleased that he will be remaining on the Board of Directors," said Dr. Fogarty.

About Bacchus Vascular

Bacchus Vascular, Inc. is a privately-held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company's Trellis(R) Peripheral Infusion System and other products.

For more information, visit http://www.bacchusvascular.com.


'/>"/>
SOURCE Bacchus Vascular Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
2. People who fight wars may be at high risk of cardiovascular disease
3. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
4. High iron levels may cause Cardiovascular Disease in women
5. Erectile dysfunction (ED) signals vascular disease
6. Drug Effective for Vascular Dementia
7. Air Pollution said To Increase Risk of Cardiovascular Disease
8. Link Between Alcohol Consumption And Cardiovascular Disease
9. Beer Found To Be Effective In Fighting Cardiovascular Disease
10. New Guidelines Found To Benefit Cardiovascular Treatment
11. Women With A High-Risk Of Cardiovascular Disease Under treated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... , ... August 16, 2017 , ... Paul Vitenas, ... Castle Connolly 2017 Top Doctor. The annual list identifies the nation’s top physicians, in ... Vitenas has made it to the top of Castle Connolly’s coveted ranking. , Castle ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection Control ... cycle, both between patient procedures and before storage, is a requisite practice crucial ... to the prevention of disease transmission and nosocomial infection as cleaning and HLD.” ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery and ... God's love, and all the many ways God shows love to those who ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... an opportunity for men and women to train as hospice volunteers. Volunteers provide ... life-limiting illness. For over 30 years, the agency has trained volunteers to be ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... FLINT, Mich. , Aug. 7, 2017 Diplomat ... appointment of Joel Saban as president, effective Aug. ... Paul Urick has decided to pursue other interests and ... period. "During his tenure, Paul has served us in multiple ... Burman,s Specialty Pharmacy in Jun. 2015 and has provided decisive, ...
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
Breaking Medicine Technology: